ArticleERJ open research2022

Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).

Iwein Gyselinck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.